CoChat

Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis

Open access
Peng, Wei, Cheng, Shumin, Bao, Zhihang, Wang, Youjing, Zhou, Wei, Wang, Junxian, Yang, Qingling, Chen, Changjie, Wang, Wenrui · 2021 · Biomedicine & Pharmacotherapy
Cited by 45

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Liver fibrosis is one of the major threats to human health. At present, anti-liver fibrosis drugs exist some problems,such as, lack of targeting, limited treatment effect and more or less toxic side effects. In order to improve the efficacy of targeted therapy for liver fibrosis, the development of a large number of nanocarriers and strategies of targeted therapy for liver fibrosis have been widely studied. In this paper, the research progress of nano-delivery vectors targeting cells related to the process of liver fibrosis in recent years was reviewed in terms of targeting vectors and the types of modified ligands, providing a new strategy for targeted cell therapy and theoretical reference for the realization of high efficient targeted therapy of liver fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2021.111342

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 45

Metadata

Authors
Peng, W., Cheng, S., Bao, Z., Wang, Y., Zhou, W., Wang, J., Yang, Q., Chen, C., & Wang, W.
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2021-05
Volume
137
Pages
111342
ISSN
0753-3322 (ISSN-L)
OpenAlex
W3132621190
Cited by
45
References
7
FWCI
1.60
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. https://app.cochat.ai/papers/10.1016/j.biopha.2021.111342
The paper
Peng, W., Cheng, S., Bao, Z., Wang, Y., Zhou, W., Wang, J., Yang, Q., Chen, C., & Wang, W. (2021). Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2021.111342

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.